Marjolein van Ballegooijen

Summary

Affiliation: Erasmus MC
Country: The Netherlands

Publications

  1. pmc Clarifying differences in natural history between models of screening: the case of colorectal cancer
    Marjolein van Ballegooijen
    Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
    Med Decis Making 31:540-9. 2011
  2. ncbi request reprint Simulation of colorectal cancer screening: What we do and do not know and does it matter
    Marjolein van Ballegooijen
    Department of Public Health, Erasmus MC, P O Box 2040, 3000 CA Rotterdam, The Netherlands
    Best Pract Res Clin Anaesthesiol 24:427-37. 2010
  3. doi request reprint Simulation of colorectal cancer screening: what we do and do not know and does it matter
    Marjolein van Ballegooijen
    Department of Public Health, Erasmus MC, PO Box 2040, 3000 CA Rotterdam, The Netherlands
    Best Pract Res Clin Gastroenterol 24:427-37. 2010
  4. pmc Study protocol: population screening for colorectal cancer by colonoscopy or CT colonography: a randomized controlled trial
    Thomas R de Wijkerslooth
    Department of Gastroenterology and Hepatology, Academic Medical Centre, Amsterdam, The Netherlands
    BMC Gastroenterol 10:47. 2010
  5. pmc Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening
    S Lucas Goede
    Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, PO Box 2040, Rotterdam 3000 CA, The Netherlands
    Gut 62:727-34. 2013
  6. pmc Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening
    Iris Lansdorp-Vogelaar
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    J Natl Cancer Inst 101:1412-22. 2009
  7. ncbi request reprint Human papillomavirus triage of women with persistent borderline or mildly dyskaryotic smears: Comparison of costs and side effects of three alternative strategies
    Matejka Rebolj
    Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
    Int J Cancer 121:1529-35. 2007
  8. ncbi request reprint Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs
    Aagje G Bais
    Department of Obstetrics and Gynaecology, Erasmus University Medical Center, Rotterdam, The Netherlands
    Int J Cancer 120:1505-10. 2007
  9. pmc Individualizing colonoscopy screening by sex and race
    Iris Lansdorp-Vogelaar
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Gastrointest Endosc 70:96-108, 108.e1-24. 2009
  10. doi request reprint Fecal occult blood testing when colonoscopy capacity is limited
    Janneke A Wilschut
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands
    J Natl Cancer Inst 103:1741-51. 2011

Collaborators

Detail Information

Publications51

  1. pmc Clarifying differences in natural history between models of screening: the case of colorectal cancer
    Marjolein van Ballegooijen
    Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
    Med Decis Making 31:540-9. 2011
    ..The authors demonstrate this problem and explore a solution for natural history using 3 independently developed colorectal cancer screening models...
  2. ncbi request reprint Simulation of colorectal cancer screening: What we do and do not know and does it matter
    Marjolein van Ballegooijen
    Department of Public Health, Erasmus MC, P O Box 2040, 3000 CA Rotterdam, The Netherlands
    Best Pract Res Clin Anaesthesiol 24:427-37. 2010
    ..Thus it is important to further develop the quality and acceptability of simulation, especially that for colorectal cancer screening...
  3. doi request reprint Simulation of colorectal cancer screening: what we do and do not know and does it matter
    Marjolein van Ballegooijen
    Department of Public Health, Erasmus MC, PO Box 2040, 3000 CA Rotterdam, The Netherlands
    Best Pract Res Clin Gastroenterol 24:427-37. 2010
    ..Thus it is important to further develop the quality and acceptability of simulation, especially that for colorectal cancer screening...
  4. pmc Study protocol: population screening for colorectal cancer by colonoscopy or CT colonography: a randomized controlled trial
    Thomas R de Wijkerslooth
    Department of Gastroenterology and Hepatology, Academic Medical Centre, Amsterdam, The Netherlands
    BMC Gastroenterol 10:47. 2010
    ....
  5. pmc Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening
    S Lucas Goede
    Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, PO Box 2040, Rotterdam 3000 CA, The Netherlands
    Gut 62:727-34. 2013
    ..This study aimed to evaluate if two-sample FIT screening is cost-effective compared with one-sample FIT...
  6. pmc Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening
    Iris Lansdorp-Vogelaar
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    J Natl Cancer Inst 101:1412-22. 2009
    ..We examined whether colorectal cancer screening would become cost saving with the widespread use of the newer, more expensive chemotherapies...
  7. ncbi request reprint Human papillomavirus triage of women with persistent borderline or mildly dyskaryotic smears: Comparison of costs and side effects of three alternative strategies
    Matejka Rebolj
    Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
    Int J Cancer 121:1529-35. 2007
    ..Therefore, we advocate including HPV testing before referring to colposcopy. Among the 3 HPV strategies, analysis of additional aspects favors implementation of immediate HPV testing...
  8. ncbi request reprint Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs
    Aagje G Bais
    Department of Obstetrics and Gynaecology, Erasmus University Medical Center, Rotterdam, The Netherlands
    Int J Cancer 120:1505-10. 2007
    ..euro 7,599). Offering self-sampling for hrHPV testing in nonresponders is an attractive adjunct to effectively increase population coverage of screening without the adverse effect of markedly increased costs per detected CIN2+ lesion...
  9. pmc Individualizing colonoscopy screening by sex and race
    Iris Lansdorp-Vogelaar
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Gastrointest Endosc 70:96-108, 108.e1-24. 2009
    ..There is increasing discussion whether colorectal cancer (CRC) screening guidelines should be individualized by sex and race...
  10. doi request reprint Fecal occult blood testing when colonoscopy capacity is limited
    Janneke A Wilschut
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands
    J Natl Cancer Inst 103:1741-51. 2011
    ..Which of these options is most clinically effective and cost-effective has yet to be established...
  11. doi request reprint Uptake of faecal immunochemical test screening among nonparticipants in a flexible sigmoidoscopy screening programme
    Lieke Hol
    Department of Gastroenterology and Hepatology, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Int J Cancer 130:2096-102. 2012
    ..Women in the target population were more likely to refuse FS than FIT screening. Countries introducing FS screening should be aware of these preferences...
  12. doi request reprint Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening
    Janneke A Wilschut
    Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands
    Gastroenterology 141:1648-55.e1. 2011
    ..We aimed to identify the most cost-effective FIT cutoff level for referral to colonoscopy based on data from these trials and allowing for differences in screening ages...
  13. doi request reprint Post-treatment CIN: randomised clinical trial using hrHPV testing for prediction of residual/recurrent disease
    Aagje G Bais
    Department of Obstetrics and Gynaecology, Erasmus University Medical Center, Rotterdam, The Netherlands
    Int J Cancer 124:889-95. 2009
    ..We advise combined cytology and hrHPV testing at 6, 12 and 24 months after treatment. Low-risk women may omit the 12 months visit, resulting in cost reduction...
  14. ncbi request reprint How many cervical cancer cases can potentially be prevented using a more sensitive screening test at young age?
    Inge M C M de Kok
    Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
    Int J Cancer 134:460-6. 2014
    ..So, as long as the current screening pattern is not changed, the majority of the cervical cancer cases at young age would still occur even when applying a more sensitive test at the younger ages. ..
  15. doi request reprint How distressing is referral to colposcopy in cervical cancer screening?: a prospective quality of life study
    Ida J Korfage
    Dept of Public Health, Erasmus MC, University Medical Center Rotterdam, P O Box 2040, 3000 CA Rotterdam, The Netherlands Electronic address
    Gynecol Oncol 132:142-8. 2014
    ..Referral for colposcopy because of abnormal Pap test results is likely to be distressing, but the extent and duration of these effects are unknown. We aimed to fill this gap...
  16. pmc Stool DNA testing to screen for colorectal cancer in the Medicare population: a cost-effectiveness analysis
    Iris Lansdorp-Vogelaar
    Erasmus Medical Center, Rotterdam, The Netherlands
    Ann Intern Med 153:368-77. 2010
    ..The Centers for Medicare & Medicaid Services considered whether to reimburse stool DNA testing for colorectal cancer screening among Medicare enrollees...
  17. pmc Incidence of cervical cancer after several negative smear results by age 50: prospective observational study
    Matejka Rebolj
    Erasmus MC, Department of Public Health, PO Box 2040, 3000 CA Rotterdam, Netherlands
    BMJ 338:b1354. 2009
    ..To determine the incidence of cervical cancer after several negative cervical smear tests at different ages...
  18. doi request reprint Are fecal immunochemical test characteristics influenced by sample return time? A population-based colorectal cancer screening trial
    Aafke H C van Roon
    Department of Gastroenterology and Hepatology, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Am J Gastroenterol 107:99-107. 2012
    ..However, hemoglobin (Hb) degradation over time may influence FIT outcome. We therefore evaluated the effect of sample return time on FIT performance characteristics in a population-based CRC screening trial...
  19. pmc How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer?
    Janneke A Wilschut
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Cancer 117:4166-74. 2011
    ..The authors investigated optimal screening strategies for individuals with various degrees of family history of CRC based on a cost-effectiveness analysis...
  20. doi request reprint Inter-observer variation in the histological diagnosis of polyps in colorectal cancer screening
    Paul G van Putten
    Department of Gastroenterology and Hepatology, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Histopathology 58:974-81. 2011
    ..To determine the inter-observer variation in the histological diagnosis of colorectal polyps...
  21. pmc Risk of cervical cancer after completed post-treatment follow-up of cervical intraepithelial neoplasia: population based cohort study
    Matejka Rebolj
    Department of Public Health, Erasmus MC, Rotterdam, Netherlands
    BMJ 345:e6855. 2012
    ....
  22. pmc Contribution of screening and survival differences to racial disparities in colorectal cancer rates
    Iris Lansdorp-Vogelaar
    Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
    Cancer Epidemiol Biomarkers Prev 21:728-36. 2012
    ..We estimated how much of these disparities could be explained by differences in CRC screening and stage-specific relative CRC survival...
  23. doi request reprint Anxiety and borderline PAP smear results
    Ida J Korfage
    Dept of Public Health, Erasmus MC, University Medical Center Rotterdam, Room Ae 108, PO Box 2040, 3000 CA Rotterdam, The Netherlands
    Eur J Cancer 46:134-41. 2010
    ..We compared quality of life and anxiety in women with BMD and a reference group of screening participants who were awaiting smear taking...
  24. doi request reprint Liquid-based cervical cytology using ThinPrep technology: weighing the pros and cons in a cost-effectiveness analysis
    Esther W de Bekker-Grob
    Department of Public Health, Erasmus MC University Medical Centre Rotterdam, Rotterdam, The Netherlands
    Cancer Causes Control 23:1323-31. 2012
    ..Based on the results of a Dutch randomised controlled trial, we conducted cost-effectiveness threshold analyses to investigate under what circumstances manually screened ThinPrep LBC is cost-effective for screening...
  25. pmc At what costs will screening with CT colonography be competitive? A cost-effectiveness approach
    Iris Lansdorp-Vogelaar
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Int J Cancer 124:1161-8. 2009
    ..Our estimate of 43% is considerably lower than previous estimates in literature, because previous studies only compared CTC screening to 10-yearly colonoscopy, where we compared to different intervals of colonoscopy screening...
  26. doi request reprint Parental decisional strategies regarding HPV vaccination before media debates: a focus group study
    Robine Hofman
    Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands
    J Health Commun 18:866-80. 2013
    ..To facilitate informed decision making, which requires central processing, personally relevant messages about the knowns and unknowns regarding the effects of HPV vaccination should be provided. ..
  27. doi request reprint Health-related quality of life in cervical cancer survivors: a population-based survey
    Ida J Korfage
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Int J Radiat Oncol Biol Phys 73:1501-9. 2009
    ..In a population-based sample of cervical cancer survivors, health-related quality of life (HRQoL) was assessed 2-10 years postdiagnosis...
  28. ncbi request reprint National Polyp Study data: evidence for regression of adenomas
    Franka Loeve
    Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands
    Int J Cancer 111:633-9. 2004
    ..This lowers the expectations for the effects of colorectal cancer screening strategies that focus on adenoma detection...
  29. ncbi request reprint Triage using HPV-testing in persistent borderline and mildly dyskaryotic smears: proposal for new guidelines
    Aagje G Bais
    Department of Obstetrics and Gynaecology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands
    Int J Cancer 116:122-9. 2005
    ..For hrHPV positive women, a repeat hrHPV test after another 6 months is suggested. Referral is only required if persistence of hrHPV is established...
  30. doi request reprint No increased risk for cervical cancer after a broader definition of a negative Pap smear
    Matejka Rebolj
    Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
    Int J Cancer 123:2632-5. 2008
    ....
  31. ncbi request reprint How much can current interventions reduce colorectal cancer mortality in the U.S.? Mortality projections for scenarios of risk-factor modification, screening, and treatment
    Iris Vogelaar
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, The Netherlands
    Cancer 107:1624-33. 2006
    ..This study assessed the potential reduction in CRC mortality that may be achieved through further dissemination of current interventions for risk-factor modification, screening, and treatment...
  32. doi request reprint Features of adenoma and colonoscopy associated with recurrent colorectal neoplasia based on a large community-based study
    Else Mariƫtte B van Heijningen
    Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
    Gastroenterology 144:1410-8. 2013
    ..We investigated adenoma and colonoscopy characteristics that are associated with recurrent colorectal neoplasia based on data from community-based surveillance practice...
  33. pmc Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model
    Inge M C M de Kok
    Erasmus MC, University Medical Center, Department of Public Health, PO Box 2040, 3000 CA Rotterdam, Netherlands
    BMJ 344:e670. 2012
    ....
  34. doi request reprint Trends in cervical cancer in the Netherlands until 2007: has the bottom been reached?
    Inge M C M de Kok
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Int J Cancer 128:2174-81. 2011
    ..On top of that there was an extra decrease that was compensated by a following recent increase in incidence, probably resulting from reorganization of the Dutch screening program...
  35. ncbi request reprint Cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands
    Inge M C M de Kok
    Department of Public Health, Erasmus MC, University Medical Center, 3000 CA Rotterdam, The Netherlands
    J Natl Cancer Inst 101:1083-92. 2009
    ..We examined the effect on cervical cancer incidence and mortality of adding HPV vaccination to the current Dutch cervical cancer screening situation and calculated the cost-effectiveness...
  36. ncbi request reprint Monitoring a national cancer prevention program: successful changes in cervical cancer screening in the Netherlands
    Matejka Rebolj
    Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
    Int J Cancer 120:806-12. 2007
    ..In conclusion, the 1996 changes in protocols and guidelines, and their implementation have increased coverage and efficiency, and decreased the screening-induced negative side effects...
  37. doi request reprint Informed choice on Pap smear still limited by lack of knowledge on the meaning of false-positive or false-negative test results
    Ida J Korfage
    Dept of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Patient Educ Couns 85:214-8. 2011
    ..Screening for cervical cancer may have favourable or unfavourable effects at the individual level. This study assesses whether invitees in The Netherlands made an informed choice about screen uptake...
  38. pmc A novel hypothesis on the sensitivity of the fecal occult blood test: Results of a joint analysis of 3 randomized controlled trials
    Iris Lansdorp-Vogelaar
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, The Netherlands
    Cancer 115:2410-9. 2009
    ..In addition to 2 usual hypotheses on the sensitivity of FOBT, we tested a novel hypothesis where sensitivity is linked to the stage of clinical diagnosis in the situation without screening...
  39. doi request reprint Increased risk of adenomas in individuals with a family history of colorectal cancer: results of a meta-analysis
    Janneke A Wilschut
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands
    Cancer Causes Control 21:2287-93. 2010
    ..Our aim is to estimate the relative difference in adenoma prevalence and its age-pattern in individuals with a family history of colorectal cancer compared to those without...
  40. pmc Parents' preferences for vaccinating daughters against human papillomavirus in the Netherlands: a discrete choice experiment
    Robine Hofman
    Department of Public Health Erasmus MC, University Medical Centre, Rotterdam, P, O, Box 2040 3000, CA, The Netherlands
    BMC Public Health 14:454. 2014
    ....
  41. pmc Multicohort models in cost-effectiveness analysis: why aggregating estimates over multiple cohorts can hide useful information
    James F O'Mahony
    Department of Public Health, Erasmus MC, Erasmus University, Rotterdam, The Netherlands
    Med Decis Making 33:407-14. 2013
    ....
  42. ncbi request reprint Human papillomavirus testing for triage of women referred because of abnormal smears. a decision analysis considering outcomes and costs
    Willem Jan Meerding
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, P O Box 1738, 3000 DR Rotterdam, The Netherlands
    J Clin Epidemiol 55:1025-32. 2002
    ..For women with severe dyskaryosis, direct treatment should be seriously considered...
  43. ncbi request reprint Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands
    Anita B Bos
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Int J Cancer 119:2372-5. 2006
    ..We conclude that increasing screening participation has much more potential for further reducing cervical cancer incidence than reducing the screening interval, increasing the age range or having a screening test with higher sensitivity...
  44. ncbi request reprint [Unequal discounting of health care costs and effects causes confusion]
    Marjolein van Ballegooijen
    Erasmus Medisch Centrum, afd Maatschappelijke Gezondheidszorg, Rotterdam, The Netherlands
    Ned Tijdschr Geneeskd 154:A1970. 2010
    ..We show how the use of unequal discount rates leads to confusing cost-effectiveness results and why further implementation guidelines are essential...
  45. doi request reprint Practical implications of differential discounting in cost-effectiveness analyses with varying numbers of cohorts
    James F O'Mahony
    Department of Public Health, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Value Health 14:438-42. 2011
    ..To call attention to the influence of the number of birth-cohorts used in cost-effectiveness analysis (CEA) models on incremental cost-effectiveness ratios (ICERs) under differential discounting...
  46. doi request reprint Would the effect of HPV vaccination on non-cervical HPV-positive cancers make the difference for its cost-effectiveness?
    Inge M C M de Kok
    Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
    Eur J Cancer 47:428-35. 2011
    ..Observed combinations of these parameters in different countries show a decrease in the CER between 10% and 31%...
  47. doi request reprint Girls' preferences for HPV vaccination: a discrete choice experiment
    Esther W de Bekker-Grob
    Department of Public Health, Erasmus MC University Medical Centre Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands
    Vaccine 28:6692-7. 2010
    ....
  48. pmc Increasing girls' knowledge about human papillomavirus vaccination with a pre-test and a national leaflet: a quasi-experimental study
    Robine Hofman
    Department of Public Health, Erasmus MC University Medical Centre Rotterdam, Rotterdam, The Netherlands
    BMC Public Health 13:611. 2013
    ..This study assesses to what extent reading an official information leaflet about HPV contributes to girls' knowledge levels, and to what extent an increase in knowledge is boosted by a pre-test measurement...
  49. ncbi request reprint Cost-effectiveness of cervical cancer screening: comparison of screening policies
    M Elske van den Akker-van Marle
    Department of Public Health, Faculty of Medicine and Health Sciences, Erasmus University Rotterdam, The Netherlands
    J Natl Cancer Inst 94:193-204. 2002
    ..e., Pap smears). We compared the efficiency of cervical cancer-screening programs by performing a cost-effectiveness analysis of cervical cancer-screening policies from high-income countries...
  50. doi request reprint Diagnostic yield improves with collection of 2 samples in fecal immunochemical test screening without affecting attendance
    Aafke H C van Roon
    Department of Gastroenterology and Hepatology, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Clin Gastroenterol Hepatol 9:333-9. 2011
    ..There are not much data on the optimal number of FITs to perform. We conducted a population-based trial to determine attendance and diagnostic yield of 1- and 2-sample FIT screening...
  51. doi request reprint Women show mixed intentions regarding the uptake of HPV vaccinations in pre-adolescents: a questionnaire study
    Ida J Korfage
    Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
    Eur J Cancer 44:1186-92. 2008
    ..The general introduction of HPV vaccination, as the primary prevention of cervical cancer, is the subject of debate in the Netherlands...